Researchers at the University of Dundee in the UK have identified a new imaging technique to enable better diagnosis and management of prostate cancer.

The team observed that the shear wave elastography (SWE) ultrasound process can be a non-invasive and less expensive alternative with more accuracy and reliability in detecting cancer.

Existing diagnostic approaches such as physical examination, blood test, biopsy and MRI scans are considered unreliable, invasive and expensive with limited availability.

“The team observed that the shear wave elastography (SWE) ultrasound process can be a non-invasive and less expensive alternative with more accuracy and reliability in detecting cancer.”

University of Dundee Surgical Uro-oncology professor Ghulam Nabi said: “We are still in a position where our diagnosis of prostate cancer is extremely inefficient, leading to unnecessary treatments for many patients.

“The new method we have developed shows we can achieve much greater levels of diagnosis, including identifying the difference between cancerous and benign tissue without the need for invasive surgery.”

During the new SWE technique, the shear waves passing through a tumour are measured and leveraged to generate images of the cancerous area.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

While the method has been in use for breast cancer and liver diseases, the researchers developed a new probe to facilitate its application for prostate cancer.

In a study with about 200 patients, the ultrasound technology demonstrated capability to detect 89% of prostate cancers, identify more aggressive tumours and those that have started to metastasize.

Nabi added: “We have had cases where the SWE technique has picked up cancers which MRI did not reveal.

“We really need to see this looked at on a wider scale to build more data but there is clearly the potential to really change the way we manage prostate cancer.”